Millennium Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $65.5M | Buy |
133,300
+11,800
| +10% | +$6.4M | 0.03% | 671 |
|
|
2025
Q4 | $70.4M | Buy |
121,500
+31,600
| +35% | +$17.9M | 0.03% | 589 |
|
|
2025
Q3 | $43.6M | Sell |
89,900
-18,400
| -17% | -$8.56M | 0.02% | 976 |
|
|
2025
Q2 | $43.9M | Sell |
108,300
-17,100
| -14% | -$7.15M | 0.02% | 902 |
|
|
2025
Q1 | $62.4M | Sell |
125,400
-53,000
| -30% | -$28.7M | 0.03% | 611 |
|
|
2024
Q4 | $92.8M | Sell |
178,400
-186,800
| -51% | -$103M | 0.05% | 427 |
|
|
2024
Q3 | $226M | Buy |
365,200
+21,500
| +6% | +$12.7M | 0.11% | 139 |
|
|
2024
Q2 | $190M | Buy |
343,700
+113,700
| +49% | +$65.1M | 0.09% | 199 |
|
|
2024
Q1 | $134M | Buy |
230,000
+50,200
| +28% | +$28.2M | 0.06% | 337 |
|
|
2023
Q4 | $95.4M | Buy |
179,800
+34,900
| +24% | +$16.9M | 0.04% | 445 |
|
|
2023
Q3 | $73.3M | Buy |
144,900
+60,000
| +71% | +$32M | 0.04% | 504 |
|
|
2023
Q2 | $44.3M | Buy |
84,900
+47,600
| +128% | +$25.7M | 0.02% | 811 |
|
|
2023
Q1 | $21.5M | Sell |
37,300
-132,200
| -78% | -$74.5M | 0.01% | 1283 |
|
|
2022
Q4 | $93.3M | Sell |
169,500
-159,400
| -48% | -$84.5M | 0.05% | 411 |
|
|
2022
Q3 | $167M | Buy |
328,900
+59,700
| +22% | +$33.4M | 0.1% | 149 |
|
|
2022
Q2 | $146M | Buy |
269,200
+100
| +0% | +$55K | 0.09% | 155 |
|
|
2022
Q1 | $159M | Sell |
269,100
-3,300
| -1% | -$1.9M | 0.08% | 170 |
|
|
2021
Q4 | $182M | Buy |
272,400
+140,800
| +107% | +$87.9M | 0.09% | 177 |
|
|
2021
Q3 | $75.2M | Buy |
131,600
+3,100
| +2% | +$1.7M | 0.05% | 423 |
|
|
2021
Q2 | $64.8M | Buy |
128,500
+99,300
| +340% | +$46.9M | 0.04% | 484 |
|
|
2021
Q1 | $13.3M | Sell |
29,200
-84,300
| -74% | -$40.2M | 0.01% | 1493 |
|
|
2020
Q4 | $52.9M | Buy |
113,500
+14,100
| +14% | +$6.61M | 0.04% | 431 |
|
|
2020
Q3 | $43.9K | Buy |
99,400
+41,800
| +73% | +$17.3M | 0.05% | 381 |
|
|
2020
Q2 | $20.9M | Buy |
57,600
+6,200
| +12% | +$2.08M | 0.03% | 706 |
|
|
2020
Q1 | $14.6M | Buy |
51,400
+33,500
| +187% | +$10.6M | 0.03% | 612 |
|
|
2019
Q4 | $5.82M | Sell |
17,900
-52,600
| -75% | -$15.9M | 0.01% | 1805 |
|
|
2019
Q3 | $20.5M | Sell |
70,500
-58,400
| -45% | -$16.7M | 0.03% | 764 |
|
|
2019
Q2 | $37.9M | Buy |
128,900
+93,900
| +268% | +$25.9M | 0.06% | 455 |
|
|
2019
Q1 | $9.58M | Buy |
35,000
+25,000
| +250% | +$6.22M | 0.01% | 1293 |
|
|
2018
Q4 | $2.24M | Sell |
10,000
-15,000
| -60% | -$3.52M | ﹤0.01% | 2130 |
|
|
2018
Q3 | $6.1M | Buy |
+25,000
| New | +$5.75M | 0.01% | 1655 |
|
|
2017
Q3 | – | Sell |
-100,000
| Closed | -$17.4M | – | 3857 |
|
|
2017
Q2 | $17.4M | Buy |
+100,000
| New | +$16.8M | 0.03% | 745 |
|
|
2014
Q3 | – | Sell |
-3,300
| Closed | -$389K | – | 4014 |
|
|
2014
Q2 | $389K | Buy |
+3,300
| New | +$388K | ﹤0.01% | 2738 |
|
|
2014
Q1 | – | Sell |
-2,300
| Closed | -$256K | – | 3879 |
|
|
2013
Q4 | $256K | Buy |
+2,300
| New | +$229K | ﹤0.01% | 3147 |
|
Other funds holding TMO
VCM
Millennium Management's TMO Position: Q1 2026 in Review
Millennium Management increased its Thermo Fisher Scientific (TMO) stake by 35% in Q1 2026, buying an estimated $10M and bringing the position to 70,696 shares worth $34.7M. The position accounts for 0.01% of the portfolio, ranked #1110.
Millennium Management first reported a position in TMO in Q2 2013 and has held it in 50 quarters since. The position peaked at $313M in Q2 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Millennium Management held 70,696 shares of Thermo Fisher Scientific worth $34.7M as of Q1 2026.
- Millennium Management bought 18,432 Thermo Fisher Scientific shares in Q1 2026, an estimated $10M.
- Thermo Fisher Scientific made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1110 holding.
- Millennium Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 50 quarters since.
- Millennium Management's Thermo Fisher Scientific position peaked at $313M in Q2 2024.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.